Amyloid transthyretinkardiomyopati
Research output: Contribution to journal › Journal article › Research › peer-review
Transthyretin amyloid cardiomyopathy (ATTR-CM) resulting from deposition of transthyretin amyloid fibrils in the heart is an underrecognised cause of heart failure in the elderly and is associated with a poor life expectancy. The diagnosis can now be made by radionuclide imaging with bone tracers, provided absence of plasma-cell dyscrasia. Recent evidence has suggested a considerable prevalence of ATTR-CM, and effective treatment has become available. This review summarises these new developments, which have ushered a new era in the detection and clinical management of ATTR-CM.
Translated title of the contribution | Transthyretin amyloid cardiomyopathy |
---|---|
Original language | Danish |
Article number | V11190627 |
Journal | Ugeskrift for Laeger |
Volume | 182 |
Issue number | 6 |
Number of pages | 5 |
ISSN | 0041-5782 |
Publication status | Published - 2020 |
Links
- https://ugeskriftet.dk/files/scientific_article_files/2020-01/v11190627_0.pdf
Final published version
ID: 260057439